Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma. Santoro A, Moskowitz AJ, Ferrari S, Carlo-Stella C, et al. Blood 2023 Mar 10:blood.2022017951. doi: 10.1182/blood.2022017951.

Read + Share

Amedeo Smart

Independent Medical Education

Santoro A, Moskowitz AJ, Ferrari S, Carlo-Stella C, et al. Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma. Blood 2023 Mar 10:blood.2022017951. doi: 10.1182/blood.2022017951.
PMID: 36898084